Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 106

    1.

    The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.

    Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL Jr, Hahn T.

    Biol Blood Marrow Transplant. 2008 Feb;14(2):137-80. Review.PMID: 18215777 [PubMed - indexed for MEDLINE]Related articles

    2.

    Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

    Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ.

    J Clin Oncol. 2006 Jul 1;24(19):3121-7. Epub 2006 Jun 5.PMID: 16754935 [PubMed - indexed for MEDLINE]Related articles

    3.

    Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

    Morgensztern D, Rosado MF, Raez LE, Santos ES, Cassileth PA.

    Leuk Lymphoma. 2005 Feb;46(2):297-8. No abstract available. PMID: 15621818 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

    Cassileth PA, Lee SJ, Litzow MR, Miller KB, Stadtmauer EA, Tallman MS, Lazarus HM, Bennett JM, Paietta E, Dewald GW, Rowe JM; Eastern Cooperative Oncology Group.

    Leuk Lymphoma. 2005 Jan;46(1):55-61.PMID: 15621781 [PubMed - indexed for MEDLINE]Related articles

    5.

    Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.

    Raez LE, Cassileth PA, Schlesselman JJ, Sridhar K, Padmanabhan S, Fisher EZ, Baldie PA, Podack ER.

    J Clin Oncol. 2004 Jul 15;22(14):2800-7.PMID: 15254047 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488.

    Oken MM, Lee S, Kay NE, Knospe W, Cassileth PA.

    Leuk Lymphoma. 2004 Jan;45(1):79-84.PMID: 15061201 [PubMed - indexed for MEDLINE]Related articles

    7.

    Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.

    Tallman MS, Kim HT, Paietta E, Bennett JM, Dewald G, Cassileth PA, Wiernik PH, Rowe JM; Eastern Cooperative Oncology Group.

    J Clin Oncol. 2004 Apr 1;22(7):1276-86. Epub 2004 Feb 17.PMID: 14970186 [PubMed - indexed for MEDLINE]Related articles

    8.

    Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma.

    Raez LE, Cassileth PA, Schlesselman JJ, Padmanabhan S, Fisher EZ, Baldie PA, Sridhar K, Podack ER.

    Cancer Gene Ther. 2003 Nov;10(11):850-8.PMID: 14605671 [PubMed - indexed for MEDLINE]Related articles

    9.

    A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).

    Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM; Eastern Cooperative Oncology Group Study.

    Leuk Lymphoma. 2003 Sep;44(9):1515-21.PMID: 14565653 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.

    Paietta E, Neuberg D, Bennett JM, Dewald G, Rowe JM, Cassileth PA, Cripe L, Tallman MS, Wiernik PH; Eastern Cooperative Oncology Group.

    Leukemia. 2003 Aug;17(8):1544-50.PMID: 12886241 [PubMed - indexed for MEDLINE]Related articles

    11.

    Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

    Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR.

    Blood. 2000 Dec 15;96(13):4075-83.PMID: 11110676 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.

    Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM, Rowe JM.

    Blood. 2000 Oct 1;96(7):2405-11.PMID: 11001891 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483).

    Robles C, Kim KM, Oken MM, Bennett JM, Letendre L, Wiernik PH, O'Connell MJ, Cassileth PA.

    Leukemia. 2000 Aug;14(8):1349-53.PMID: 10942228 [PubMed - indexed for MEDLINE]Related articles

    14.

    Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group.

    Lee S, Tallman MS, Oken MM, Cassileth PA, Bennett JM, Wiernik PH, Rowe JM.

    Leukemia. 2000 Aug;14(8):1345-8.PMID: 10942227 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study.

    Kucuk O, Young ML, Habermann TM, Wolf BC, Jimeno J, Cassileth PA.

    Am J Clin Oncol. 2000 Jun;23(3):273-7.PMID: 10857892 [PubMed - indexed for MEDLINE]Related articles

    16.

    Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group.

    Hochster HS, Oken MM, Winter JN, Gordon LI, Raphael BG, Bennett JM, Cassileth PA.

    J Clin Oncol. 2000 Mar;18(5):987-94.PMID: 10694548 [PubMed - indexed for MEDLINE]Related articles

    17.

    A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.

    Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick J, Ghosh C, Flynn P, Cassileth PA.

    Blood. 1999 Nov 15;94(10):3307-14.PMID: 10552939 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells.

    Restrepo A, Albrecht F, Raez LE, Fernandez HF, Nassiri M, Byrne G Jr, Cassileth PA.

    Crit Rev Oncog. 1999;10(3):239-45. Review.PMID: 10468183 [PubMed - indexed for MEDLINE]Related articles

    19.

    Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

    Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC.

    Clin Cancer Res. 1999 Jul;5(7):1665-70.PMID: 10430066 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?

    Restrepo A, Raez LE, Byrne GE Jr, Johnson T, Ossi P, Benedetto P, Hamilton K, Whitcomb CC, Cassileth PA.

    Crit Rev Oncog. 1998;9(3-4):269-73.PMID: 10201631 [PubMed - indexed for MEDLINE]Related articles

    21.

    Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).

    Raez LE, Patel P, Feun L, Restrepo A, Raub WA Jr, Cassileth PA.

    Crit Rev Oncog. 1998;9(3-4):199-208.PMID: 10201628 [PubMed - indexed for MEDLINE]Related articles

    22.

    Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.

    Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, Wiernik PH.

    Leukemia. 1998 Dec;12(12):1881-5.PMID: 9844918 [PubMed - indexed for MEDLINE]Related articles

    23.

    Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.

    Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH.

    N Engl J Med. 1998 Dec 3;339(23):1649-56.PMID: 9834301 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Interleukin-2 therapy for advanced chronic myeloid leukemia.

    Goodman M, Spector N, Rodrigues G, Cassileth PA.

    Leukemia. 1998 Nov;12(11):1682-4.PMID: 9823941 [PubMed - indexed for MEDLINE]Related articles

    25.

    Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.

    Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth PA.

    Bone Marrow Transplant. 1998 May;21(9):923-6.PMID: 9613785 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.

    Loeffler M, Brosteanu O, Hasenclever D, Sextro M, Assouline D, Bartolucci AA, Cassileth PA, Crowther D, Diehl V, Fisher RI, Hoppe RT, Jacobs P, Pater JL, Pavlovsky S, Thompson E, Wiernik P.

    J Clin Oncol. 1998 Mar;16(3):818-29.PMID: 9508162 [PubMed - indexed for MEDLINE]Related articles

    27.

    Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.

    Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS, Bennett JM, Wiernik PH.

    Br J Haematol. 1998 Feb;100(2):265-72.PMID: 9488612 [PubMed - indexed for MEDLINE]Related articles

    28.

    A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma.

    Morrell LE, Lee YJ, Hurley J, Arias M, Mies C, Richman SP, Fernandez H, Donofrio KA, Raub WA Jr, Cassileth PA.

    Cancer. 1998 Feb 1;82(3):503-11.PMID: 9452268 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

    Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E, Wiernik PH, Rowe JM.

    Cancer. 1997 Dec 1;80(11 Suppl):2205-9.PMID: 9395035 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.

    Bennett JM, Cassileth PA, Paietta E, Rowe JM, Wiernik PH.

    Leukemia. 1996 Aug;10(8):1365. No abstract available. PMID: 8709645 [PubMed - indexed for MEDLINE]Related articles

    31.

    Treatment of adult patients with acute lymphocytic leukemia in relapse.

    Mazza JJ, Leong T, Rowe JM, Wiernik PH, Cassileth PA.

    Leuk Lymphoma. 1996 Jan;20(3-4):317-9.PMID: 8624473 [PubMed - indexed for MEDLINE]Related articles

    32.

    A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

    Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH.

    Blood. 1995 Jul 15;86(2):457-62.PMID: 7605984 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapy.

    Friedenberg WR, Miller HJ, Marx JJ Jr, Schloesser LL, Reding DJ, Mazza JJ, Hocking WG, Mercier RJ, Raich PC, Cassileth PA.

    Am J Clin Oncol. 1995 Apr;18(2):105-10.PMID: 7900701 [PubMed - indexed for MEDLINE]Related articles

    34.

    Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

    Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchison RE, Corbett WE, Cassileth PA, Habermann T, Golomb H, et al.

    J Clin Oncol. 1995 Apr;13(4):974-82.PMID: 7707126 [PubMed - indexed for MEDLINE]Related articles

    35.

    Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer.

    Cassileth PA, Podack E, Sridhar K, Savaraj N, Hanlon J.

    Hum Gene Ther. 1995 Mar;6(3):369-83. No abstract available. PMID: 7779919 [PubMed - indexed for MEDLINE]Related articles

    36.

    Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.

    Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA.

    Cancer. 1995 Feb 1;75(3):865-73.PMID: 7530168 [PubMed - indexed for MEDLINE]Related articles

    37.

    Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group study.

    Friedenberg WR, Anderson J, Wolf BC, Cassileth PA, Oken MM.

    Cancer. 1993 May 15;71(10):2983-9.PMID: 8490825 [PubMed - indexed for MEDLINE]Related articles

    38.

    Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.

    Talbot GH, Cassileth PA, Paradiso L, Correa-Coronas R, Bond L.

    Antimicrob Agents Chemother. 1993 Mar;37(3):474-82.PMID: 8460916 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Autologous bone marrow transplant in acute myeloid leukemia in first remission.

    Cassileth PA, Andersen J, Lazarus HM, Colvin OM, Bennett JM, Stadtmauer EA, Kaizer H, Weiner RS, Edelstein M, Oken MM.

    J Clin Oncol. 1993 Feb;11(2):314-9.PMID: 8426209 [PubMed - indexed for MEDLINE]Related articles

    40.

    Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

    Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH.

    Leukemia. 1992 Nov;6 Suppl 4:75-7. No abstract available. PMID: 1434840 [PubMed - indexed for MEDLINE]Related articles

    41.

    The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study.

    Miller KB, Kim K, Morrison FS, Winter JN, Bennett JM, Neiman RS, Head DR, Cassileth PA, O'Connell MJ.

    Ann Hematol. 1992 Oct;65(4):162-8. Erratum in: Ann Hematol 1993 Mar;66(3):164. Kyungmann K [corrected to Kim K]. PMID: 1420504 [PubMed - indexed for MEDLINE]Related articles

    42.

    Phase II clinical trial of carboplatin in relapsed and refractory leukemia.

    Vogler WR, Harrington DP, Winton EF, Lazarus HM, Bennett JM, Cassileth PA, Oken MM.

    Leukemia. 1992 Oct;6(10):1072-5.PMID: 1405761 [PubMed - indexed for MEDLINE]Related articles

    43.

    Recertification in hematology. Hematology Board of the American Board of Internal Medicine.

    Nienhuis AW, Armitage JO, Cassileth PA, Foinstein DI, Furie BA, LaBuglio AF, Moore A.

    Blood. 1992 Jul 15;80(2):564-5. No abstract available. PMID: 1627812 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Varying intensity of postremission therapy in acute myeloid leukemia.

    Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM, McGlave PB, Edelstein M, Harrington DP, O'Connell MJ.

    Blood. 1992 Apr 15;79(8):1924-30.PMID: 1562720 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.

    Habermann TM, Andersen JW, Cassileth PA, Bennett JM, Oken MM.

    Br J Haematol. 1992 Apr;80(4):466-71.PMID: 1581231 [PubMed - indexed for MEDLINE]Related articles

    46.

    Marrow fibrosis associated with a Philadelphia chromosome.

    Nowell PC, Kant JA, Finan JB, Cassileth PA, Hanson CA.

    Cancer Genet Cytogenet. 1992 Mar;59(1):89-92.PMID: 1372840 [PubMed - indexed for MEDLINE]Related articles

    47.

    Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.

    Hochster HS, Kim KM, Green MD, Mann RB, Neiman RS, Oken MM, Cassileth PA, Stott P, Ritch P, O'Connell MJ.

    J Clin Oncol. 1992 Jan;10(1):28-32.PMID: 1727921 [PubMed - indexed for MEDLINE]Related articles

    48.

    Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.

    Cassileth PA, Andersen JW, Bennett JM, Hoagland HC, Mazza JJ, O'Connell MC, Paietta E, Wiernik P.

    Leukemia. 1992;6 Suppl 2:178-81. No abstract available. PMID: 1578927 [PubMed - indexed for MEDLINE]Related articles

    49.

    Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.

    Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E, et al.

    Leukemia. 1992;6 Suppl 2:116-9.PMID: 1578910 [PubMed - indexed for MEDLINE]Related articles

    50.

    Autologous bone marrow transplantation with in vitro chemotherapy purge in first remission of acute myeloid leukemia.

    Stadtmauer EA, Edelstein M, Lin E, Spitalnik S, Silberstein L, Cassileth PA.

    Prog Clin Biol Res. 1992;377:273-9. No abstract available. PMID: 1438425 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...